Works matching AU Ross, Dara S.

Results: 23

Genomic landscape of breast cancer in elderly patients.

Published in:

NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00781-4

By:

Selenica, Pier;
Dopeso, Higinio;
Repetto, Matteo;
Basili, Thais;
Gazzo, Andrea M.;
Schwartz, Christopher J.;
Derakhshan, Fatemeh;
Marra, Antonio;
Ferrando, Lorenzo;
Beets-Tan, Regina G. H.;
Wen, Y. H.;
Ross, Dara S.;
Brogi, Edi;
Zhang, Hong;
Norton, Larry;
Chandarlapaty, Sarat;
Razavi, Pedram;
Mandelker, Diana;
Reis-Fiho, Jorge S.;
Weigelt, Britta

Publication type:

Article

Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using <sup>89</sup>Zr-Trastuzumab PET/CT.

Published in:

Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1523, doi. 10.2967/jnumed.115.172031

By:

Ulaner, Gary A.;
Hyman, David M.;
Ross, Dara S.;
Corben, Adriana;
Chandarlapaty, Sarat;
Goldfarb, Shari;
McArthur, Heather;
Erinjeri, Joseph P.;
Solomon, Stephen B.;
Kolb, Hartmuth;
Lyashchenko, Serge K.;
Lewis, Jason S.;
Carrasquillo, Jorge A.

Publication type:

Article

HER2 assessment by bright‐field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma.

Published in:

Cancer Cytopathology, 2019, v. 127, n. 11, p. 684, doi. 10.1002/cncy.22184

By:

Edelweiss, Marcia;
Sebastiao, Ana Paula Martins;
Oen, Handy;
Kracun, Mihaela;
Serrette, Rene;
Ross, Dara S.

Publication type:

Article

The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapy.

Published in:

Cancer Cytopathology, 2019, v. 127, n. 7, p. 428, doi. 10.1002/cncy.22124

By:

Hechtman, Jaclyn F.;
Ross, Dara S.

Publication type:

Article

Optimization of Scanning Protocol for AI-Integrated Assessment of HER2 Dual Bright-Field In-Situ Hybridization Application in Breast Cancer.

Published in:

Bioengineering (Basel), 2025, v. 12, n. 6, p. 569, doi. 10.3390/bioengineering12060569

By:

Bakoglu Malinowski, Nilay;
Ohnishi, Takashi;
Cesmecioglu, Emine;
Ross, Dara S.;
Tsukamoto, Tetsuya;
Yagi, Yukako

Publication type:

Article

Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice.

Published in:

Pathology & Oncology Research, 2024, p. 1, doi. 10.3389/pore.2024.1611826

By:

Chiu-Hsiang Connie Liao;
Bakoglu, Nilay;
Cesmecioglu, Emine;
Hanna, Matthew;
Pareja, Fresia;
Wen, Hannah Y.;
D'Alfonso, Timothy M.;
Brogi, Edi;
Yagi, Yukako;
Ross, Dara S.

Publication type:

Article

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00592-5

By:

Moss, Nelson S.;
Singh, Jolene M.;
Reiner, Anne S.;
Drago, Joshua Z.;
Modi, Shanu;
Seidman, Andrew D.;
Chandarlapaty, Sarat;
Ross, Dara S.

Publication type:

Article

Skin adnexal carcinoma with BRD3‐NUTM2B fusion.

Published in:

Journal of Cutaneous Pathology, 2021, v. 48, n. 12, p. 1508, doi. 10.1111/cup.14107

By:

Rubio Gonzalez, Belen;
Ortiz, Michael V.;
Ross, Dara S.;
Busam, Klaus J.

Publication type:

Article

Standardizing HER2 immunohistochemistry assessment: calibration of color and intensity variation in whole slide imaging caused by staining and scanning.

Published in:

Applied Microscopy, 2023, v. 53, n. 1, p. 1, doi. 10.1186/s42649-023-00091-8

By:

Ohnishi, Chie;
Ohnishi, Takashi;
Ntiamoah, Peter;
Ross, Dara S.;
Yamaguchi, Masahiro;
Yagi, Yukako

Publication type:

Article

Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.

Published in:

Breast Journal, 2017, v. 23, n. 2, p. 182, doi. 10.1111/tbj.12706

By:

Ross, Dara S.;
Giri, Dilip D.;
Akram, Muzaffar M.;
Catalano, Jeffrey P.;
Olcese, Cristina;
Van Zee, Kimberly J.;
Brogi, Edi

Publication type:

Article

Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

Published in:

Breast Journal, 2015, v. 21, n. 5, p. 514, doi. 10.1111/tbj.12445

By:

Conlon, Niamh;
Ross, Dara S.;
Howard, Jane;
Catalano, Jeffrey P.;
Dickler, Maura N.;
Tan, Lee K.

Publication type:

Article

Automatic quantification of HER2 gene amplification in invasive breast cancer from chromogenic in situ hybridization whole slide images.

Published in:

Journal of Medical Imaging, 2019, v. 6, n. 4, p. 1, doi. 10.1117/1.JMI.6.4.047501

By:

Hossain, Md. Shakhawat;
Hanna, Matthew G.;
Naohiro Uraoka;
Tomoya Nakamura;
Edelweiss, Marcia;
Brogi, Edi;
Hameed, Meera R.;
Masahiro Yamaguchi;
Ross, Dara S.;
Yukako Yagi

Publication type:

Article

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast.

Published in:

Histopathology, 2021, v. 79, n. 5, p. 836, doi. 10.1111/his.14433

By:

Kuba, Maria Gabriela;
Xu, Bin;
D'Angelo, Sandra P;
Rosenbaum, Evan;
Plitas, George;
Ross, Dara S;
Brogi, Edi;
Antonescu, Cristina R

Publication type:

Article

Next‐generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline

Published in:

Histopathology, 2021, v. 78, n. 4, p. 498, doi. 10.1111/his.14241

By:

Hoda, Raza S;
Bowman, Anita S;
Zehir, Ahmet;
Razavi, Pedram;
Brogi, Edi;
Ladanyi, Marc;
Arcila, Maria E;
Wen, Hannah Y;
Ross, Dara S

Publication type:

Article

Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers.

Published in:

PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017876

By:

Yao-Tseng Chen;
Ross, Dara S.;
Chiu, Rita;
Zhou, Xi K.;
Yunn-Yi Chen;
Peishan Lee;
Hoda, Syed A.;
Simpson, Andrew J.;
Old, Lloyd J.;
Caballero, Otavia;
Neville, A. Munro

Publication type:

Article

Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.

Published in:

Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 349, doi. 10.1007/s10549-023-06865-8

By:

Hogan, Molly P.;
Horvat, Joao V.;
Ross, Dara S.;
Sevilimedu, Varadan;
Jochelson, Maxine S.;
Kirstein, Laurie J.;
Goldfarb, Shari B.;
Comstock, Christopher E.;
Sung, Janice S.

Publication type:

Article

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

Published in:

Breast Cancer Research & Treatment, 2022, v. 195, n. 3, p. 341, doi. 10.1007/s10549-022-06669-2

By:

Walsh, Elaine M.;
Gucalp, Ayca;
Patil, Sujata;
Edelweiss, Marcia;
Ross, Dara S.;
Razavi, Pedram;
Modi, Shanu;
Iyengar, Neil M.;
Sanford, Rachel;
Troso-Sandoval, Tiffany;
Gorsky, Mila;
Bromberg, Jacqueline;
Drullinsky, Pamela;
Lake, Diana;
Wong, Serena;
DeFusco, Patricia Ann;
Lamparella, Nicholas;
Gupta, Ranja;
Tabassum, Tasmila;
Boyle, Leigh Ann

Publication type:

Article

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Published in:

Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 61, doi. 10.1007/s10549-019-05295-9

By:

Krystel-Whittemore, Melissa;
Xu, Jin;
Brogi, Edi;
Ventura, Katia;
Patil, Sujata;
Ross, Dara S.;
Dang, Chau;
Robson, Mark;
Norton, Larry;
Morrow, Monica;
Wen, Hannah Y.

Publication type:

Article

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.

Published in:

NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00250-8

By:

da Silva, Edaise M.;
Selenica, Pier;
Vahdatinia, Mahsa;
Pareja, Fresia;
Da Cruz Paula, Arnaud;
Ferrando, Lorenzo;
Gazzo, Andrea M.;
Dopeso, Higinio;
Ross, Dara S.;
Bakhteri, Ariya;
Riaz, Nadeem;
Chandarlapaty, Sarat;
Razavi, Pedram;
Norton, Larry;
Wen, Hannah Y.;
Brogi, Edi;
Weigelt, Britta;
Zhang, Hong;
Reis-Filho, Jorge S.

Publication type:

Article

The Diagnostic Utility of the Minimal Carcinoma Triple Stain in Breast Carcinomas.

Published in:

American Journal of Clinical Pathology, 2013, v. 139, n. 1, p. 62, doi. 10.1309/AJCPF4O0ADKFMGRJ

By:

Ross, Dara S.;
Yi-Fang Liu;
Pipa, Jennifer;
Shin, Sandra J.

Publication type:

Article

HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern.

Published in:

Archives of Pathology & Laboratory Medicine, 2021, v. 145, n. 8, p. 979, doi. 10.5858/arpa.2020-0288-OA

By:

Perron, Marjorie;
Wen, Hannah Y.;
Hanna, Matthew G.;
Brogi, Edi;
Ross, Dara S.

Publication type:

Article

Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy.

Published in:

Archives of Pathology & Laboratory Medicine, 2021, v. 145, n. 6, p. 728, doi. 10.5858/arpa.2020-0293-OA

By:

Zeng, Jennifer;
Edelweiss, Marcia;
Ross, Dara S.;
Bin Xu;
Moo, Tracy-Ann;
Brogi, Edi;
D'Alfonso, Timothy M.

Publication type:

Article

Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2/CEP17 Ratio <2.0 and Average HER2 Copy Number ≤4.0 and <6.0.

Published in:

Archives of Pathology & Laboratory Medicine, 2020, v. 144, n. 5, p. 597, doi. 10.5858/arpa.2019-0307-OA

By:

Hoda, Raza S.;
Brogi, Edi;
Jin Xu;
Ventura, Katia;
Ross, Dara S.;
Chau Dang;
Robson, Mark;
Norton, Larry;
Morrow, Monica;
Wen, Hannah Y.

Publication type:

Article